Articles
Pharma social media scan: we're not in Kansas anymore

Pharma social media scan: we're not in Kansas anymore

Emma D’Arcy continues her monthly round-up of pharma digital activity with a view this time on regulatory restraints when it comes to social media. March is a busy month in the world of pharmaceutical digital marketing, there are two specialist conferences where you hope to swap ideas, and gain insights and...

Articles
WAIMO: What are IDEAs actually made of?

WAIMO: What are IDEAs actually made of?

In the final piece of his WAIMO series, Mike Rea provides a roundup of the series and asks the ultimate question - what are ideas actually made of? As this series draws to a close, it is interesting to think about what IDEAs are made of (I realise I just made a challengeable assumption there…), but the question any rational reader would pose is...

Articles
Cross-roads for pharma in India

Cross-roads for pharma in India

Pharma in India has altered dramatically over the last decade. Dinar Kale takes a look at the changes that have occurred and asks what the future holds for Indian pharma. Over the past 50 years, the Indian pharmaceutical industry has gone from being copy-cat followers to partners of choice for…

Sales & Marketing

Sales & Marketing
Solution Spotlight: BrandPRO Biopharma
Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Digital

Market Access

Editor's Picks

  1. UK budget includes £1bn biopharma investment package
  2. HHS doubles down on controversial peptides plan
  3. Lilly's triple G overpowers Ozempic in diabetes trial
  4. UK puts £100m into "world-first" AI biosecurity facility
  5. US gives $99m for Ebola jab project, as cases spread in Africa

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more